Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Neuronal activity biases axon selection for myelination in vivo.
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
A methylenetetrahydrofolate reductase gene polymorphism in multiple sclerosis.
Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.
Lung volume recruitment in multiple sclerosis.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
Internet-based home training is capable to improve balance in multiple sclerosis: a comparative trial with hippotherapy.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
Oligodendroglial Argonaute protein Ago2 associates with molecules of the Mbp mRNA localization machinery and is a downstream target of Fyn kinase.
Aging diminishes the resistance of AO rats to EAE: putative role of enhanced generation of GM-CSF Expressing CD4+ T cells in aged rats.
The role of N-Glycan modification of TNFR1 in inflammatory microglia activation.
Pseudoneoplasms in the nervous system.
In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System.
Molecular approach to targeted therapy for multiple sclerosis.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Pages
« first
‹ previous
…
575
576
577
578
579
580
581
582
583
…
next ›
last »